Cipla shares gains on partner's South Africa contract win
Shares in drugmaker Cipla rose 1.4 percent after Cipla Medpro won a share in South Africa's $667 million contract, as it supplies the bulk of Cipla Medpro's drugs.

Shares in drugmaker Cipla rose 1.4 percent after Cipla Medpro won a share in South Africa's $667 million contract, as it supplies the bulk of Cipla Medpro's drugs.
[caption id="attachment_540946" align="alignleft" width="380"]
Dealers say the company may garner revenues of $30-40 million from Cipla Medpro's contract. Getty Images[/caption]
Dealers said the company may garner revenues of $30-40 million from Cipla Medpro's contract.
South Africa on Thursday awarded a $667 million contract to supply life-prolonging HIV medicine to 12 international and domestic firms, including Cipla Medpro, to deal with its biggest health problem.
Cipla also plans to offer $215 million for a majority stake in South Africa's Cipla Medpro to strengthen its presence in Africa's fast-growing market for cheap, generic versions of branded drugs.
Reuters

BCCI earned more than Rs 2,400 crore in IPL 2022, reveal documents
Eight Russian judokas barred from world championships after Ukraine boycott
Old video of Donald Trump listening to Taylor Swift’s ‘Blank Space’ takes over internet; watch
SA20: Ex-New Zealand all-rounder Jacob Oram appointed MI Cape Town bowling coach
FIFA World Cup: Morgan Freeman, Jung Kook headline day one before Ecuador defeats hosts Qatar
